Literature DB >> 12183033

Seizure suppression by adenosine A(2A) receptor activation in a rat model of audiogenic brainstem epilepsy.

Alexander Huber1, Martin Güttinger, Hanns Möhler, Detlev Boison.   

Abstract

Adenosine is known to suppress seizure activity mainly by activation of adenosine A(1) receptors. However, little is known about the potential involvement of other types of adenosine receptors in seizure suppression. It was now tested whether activation of adenosine A(2A) receptors would be effective in the suppression of generalized brainstem seizures. Genetically epilepsy-prone rats were intraperitoneally injected with increasing doses of the A(2A) receptor agonist, 5'-(N-cyclopropyl)-carboxamido-adenosine (CPCA), and, for comparison, with the A(1) receptor agonist, 2-chloro-N(6)-cyclopentyladenosine (CCPA). Both CPCA and CCPA were effective in suppressing generalized brainstem seizures with minimal effective concentrations of 2.5 and 1.5 mg/kg, respectively. Seizure suppression was maintained when CPCA was co-injected with the peripherally acting adenosine receptor antagonist 8-(p-sulphophenyl)theophylline, suggesting that central activation of A(2A) receptors effectively contributes to seizure suppression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12183033     DOI: 10.1016/s0304-3940(02)00684-5

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  14 in total

Review 1.  Presynaptic modulation controlling neuronal excitability and epileptogenesis: role of kainate, adenosine and neuropeptide Y receptors.

Authors:  João O Malva; Ana P Silva; Rodrigo A Cunha
Journal:  Neurochem Res       Date:  2003-10       Impact factor: 3.996

Review 2.  Regulation of neurite outgrowth by G(i/o) signaling pathways.

Authors:  Kenneth D Bromberg; Ravi Iyengar; John Cijiang He
Journal:  Front Biosci       Date:  2008-05-01

3.  Role of adenosine signaling on pentylenetetrazole-induced seizures in zebrafish.

Authors:  Anna Maria Siebel; Fabiano Peres Menezes; Katiucia Marques Capiotti; Luiza Wilges Kist; Isabel da Costa Schaefer; Juliana Zanetti Frantz; Maurício Reis Bogo; Rosane Souza Da Silva; Carla Denise Bonan
Journal:  Zebrafish       Date:  2015-01-05       Impact factor: 1.985

4.  Enhanced actions of adenosine in medial entorhinal cortex layer II stellate neurons in temporal lobe epilepsy are mediated via A(1)-receptor activation.

Authors:  Nicholas J Hargus; Conor Jennings; Edward Perez-Reyes; Edward H Bertram; Manoj K Patel
Journal:  Epilepsia       Date:  2011-11-29       Impact factor: 5.864

Review 5.  Epigenetics and epilepsy prevention: The therapeutic potential of adenosine and metabolic therapies.

Authors:  Detlev Boison; Jong M Rho
Journal:  Neuropharmacology       Date:  2019-08-13       Impact factor: 5.250

6.  In Vivo Evaluation of A1 Adenosine Agonists as Novel Anticonvulsant Medical Countermeasures to Nerve Agent Intoxication in a Rat Soman Seizure Model.

Authors:  Thaddeus P Thomas; Amy Wegener; Tsung-Ming Shih
Journal:  Neurotox Res       Date:  2019-05-08       Impact factor: 3.911

7.  Tuning and fine-tuning of synapses with adenosine.

Authors:  A M Sebastião; J A Ribeiro
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

Review 8.  Triggering neurotrophic factor actions through adenosine A2A receptor activation: implications for neuroprotection.

Authors:  Ana M Sebastião; Joaquim A Ribeiro
Journal:  Br J Pharmacol       Date:  2009-06-05       Impact factor: 8.739

Review 9.  The adenosine kinase hypothesis of epileptogenesis.

Authors:  Detlev Boison
Journal:  Prog Neurobiol       Date:  2007-12-23       Impact factor: 11.685

10.  Anticonvulsant activity of B2, an adenosine analog, on chemical convulsant-induced seizures.

Authors:  Min Li; Ruixia Kang; Jiangong Shi; Gengtao Liu; Jianjun Zhang
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.